Cargando…

Admission factors associated with ICU readmission in onco-hematological critically ill patients: a retrospective cohort study

Detalles Bibliográficos
Autores principales:	Taniguchi, Leandro U, Rodrigues, Cinthia M, Pires, Ellen MC, Feliciano, Jorge PO, Vieira, Jose M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601683/ http://dx.doi.org/10.1186/cc14669

Ejemplares similares

Admission factors associated with intensive care unit readmission in critically ill oncohematological patients: a retrospective cohort study
por: Rodrigues, Cinthia Mendes, et al.
Publicado: (2016)

Reply to: Admission factors associated with intensive care unit readmission in critically ill oncohematological patients: a retrospective cohort study
por: Rodrigues, Cinthia Mendes, et al.
Publicado: (2016)

Respiratory events in ward are associated with later intensive care unit (ICU) admission and hospital mortality in onco-hematology patients not admitted to ICU after a first request
por: Doukhan, Laure, et al.
Publicado: (2017)

Is admission of hematologic malignancies in the ICU justified?
por: Gasparovic, VG, et al.
Publicado: (2015)

Standards of referrals and admissions of critically ill patients to the ICU
por: Ng, A
Publicado: (2013)

Readmission and hospital mortality after ICU discharge of critically ill cancer patients
por: Jeong, Byeong-Ho, et al.
Publicado: (2019)

Correction: Readmission and hospital mortality after ICU discharge of critically ill cancer patients
por: Jeong, Byeong-Ho, et al.
Publicado: (2019)

Chronic critical illness: reason for concern during and after ICU admission!
por: R Feijó, Carlos Augusto, et al.
Publicado: (2015)

Admission of critically ill patients with cancer to the ICU: many uncertainties remain
por: Koutsoukou, Antonia
Publicado: (2017)

Surgical Management of Rhinosinusitis in Onco-Hematological Patients
por: Di Girolamo, Stefano, et al.
Publicado: (2014)

Effects of time and day of admission on the outcome of critically ill patients admitted to ICU
por: Orsini, Jose, et al.
Publicado: (2016)

Physical Function in Critically Ill Patients during the Duration of ICU and Hospital Admission
por: Aglawe, Damini R, et al.
Publicado: (2022)

Glucocorticoids and Antivirals for HBV Reactivation in Onco-Hematologic Patients.
por: Marzano, Alfredo, et al.
Publicado: (2010)

Two cases of paralitic ileus in onco-hematologic patients
por: Carraro, Francesca, et al.
Publicado: (2012)

Safety of switching between rituximab biosimilars in onco-hematology
por: Urru, Silvana A. M., et al.
Publicado: (2021)

Editorial: Real-World evidence in onco-hematological patients
por: Vener, Claudia, et al.
Publicado: (2022)

Inflammatory and perfusion markers as risk factors and predictors of critically ill patient readmission
por: dos Santos, Moreno Calcagnotto, et al.
Publicado: (2014)

Systemic inflammatory response syndrome criteria and the prediction of hospital mortality in critically ill patients: a retrospective cohort study
por: Taniguchi, Leandro Utino, et al.
Publicado: (2017)

Top-ten infections in onco-hematological patients (2015-2017)
por: Camps, Isabel Ruiz, et al.
Publicado: (2019)

Health Related Quality of Life in Patients with Onco-hematological Diseases
por: La Nasa, Giorgio, et al.
Publicado: (2020)

Reporting reimbursement price decisions for onco-hematology drugs in Spain
por: Elvira, David, et al.
Publicado: (2023)

Development and validation of delirium prediction model for critically ill adults parameterized to ICU admission acuity
por: Cherak, Stephana J., et al.
Publicado: (2020)

ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 Patients
por: Vassiliou, Alice G., et al.
Publicado: (2021)

Hematology and Oncology in Critical Illness
por: Brandão, Leonardo R., et al.
Publicado: (2011)

Overview of Current Targeted Anti-Cancer Drugs for Therapy in Onco-Hematology
por: Crisci, Stefania, et al.
Publicado: (2019)

The profile of the onco-hematology patient in the palliative care: 4 years of experience
por: Couto, Maria Eduarda, et al.
Publicado: (2019)

Pediatric onco-hematological home care during COVID-19 pandemic
por: Amicucci, Matteo, et al.
Publicado: (2021)

Editorial: Digital health and real-world evidence in onco-hematological patients
por: Vener, Claudia, et al.
Publicado: (2023)

ICU readmission: good or bad?
por: Potter, E, et al.
Publicado: (2011)

Cancer patients with sepsis admitted to a specialized onco-medical ICU: incidence, ICU course and outcome
por: Juneja, D, et al.
Publicado: (2011)

To: Admission factors associated with intensive care unit readmission in critically ill oncohematological patients: a retrospective cohort study
por: Aydoğdu, Müge, et al.
Publicado: (2016)

Impact of Critical Illness on Resource Utilization: A Comparison of Use in the Year Before and After ICU Admission*
por: Hirshberg, Eliotte L., et al.
Publicado: (2019)

Direct admission to the intensive care unit from the emergency department and mortality in critically ill hematology patients
por: Peyrony, Olivier, et al.
Publicado: (2019)

Trends in Severity of Illness on ICU Admission and Mortality among the Elderly
por: Fuchs, Lior, et al.
Publicado: (2014)

Use of inflammatory molecules to predict the occurrence of fever in onco-hematological patients with neutropenia
por: Ribeiro, A.F. Tibúrcio, et al.
Publicado: (2013)

Virtual Reality Analgesia During Venipuncture in Pediatric Patients With Onco-Hematological Diseases
por: Atzori, Barbara, et al.
Publicado: (2018)

Cardio-onco-hematology patients’ management in the context of the current COVID-19 pandemic
por: Lorca, Rebeca, et al.
Publicado: (2020)

Immunogenicity profile after COVID-19 vaccination in patients with onco-hematological diseases
por: de Almeida, João Bosco, et al.
Publicado: (2023)

Benefits of ICU admission in critically ill patients: Whether instrumental variable methods or propensity scores should be used
por: Pirracchio, Romain, et al.
Publicado: (2011)

Sepsis prediction in critically ill patients by platelet activation markers on ICU admission: a prospective pilot study
por: Layios, Nathalie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2kc8l5q7kkf126uk2i0dfk45sg